SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-23-005994
Filing Date
2023-08-22
Accepted
2023-08-22 16:01:22
Documents
17
Period of Report
2023-08-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K coeptis_8k.htm   iXBRL 8-K 37596
2 LICENSE AGREEMENT coeptis_ex1001.htm EX-10.1 126052
3 SUBLICENSE AGREEMENT coeptis_ex1002.htm EX-10.2 82873
4 ASSET PURCHASE AGREEMENT coeptis_ex1003.htm EX-10.3 256647
5 PRESS RELEASE coeptis_ex9901.htm EX-99.1 14666
  Complete submission text file 0001683168-23-005994.txt   842165

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE coep-20230816.xsd EX-101.SCH 3263
7 XBRL DEFINITION FILE coep-20230816_def.xml EX-101.DEF 26557
8 XBRL LABEL FILE coep-20230816_lab.xml EX-101.LAB 36481
9 XBRL PRESENTATION FILE coep-20230816_pre.xml EX-101.PRE 25181
11 EXTRACTED XBRL INSTANCE DOCUMENT coeptis_8k_htm.xml XML 5076
Mailing Address 105 BRADFORD ROAD, SUITE 420 WEXFORD PA 15090
Business Address 105 BRADFORD ROAD, SUITE 420 WEXFORD PA 15090 724-934-6467
Coeptis Therapeutics Holdings, Inc. (Filer) CIK: 0001759186 (see all company filings)

IRS No.: 981465952 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39669 | Film No.: 231193428
SIC: 2836 Biological Products, (No Diagnostic Substances)